search

 Cancer Treatment Adjuvant Protocol - Prostate Cancer

0 comments

file time: 2008-03-05

file siez:89.0KB

filetype:pdf

Click Here To Download...

Cancer Treatment Adjuvant Ingredients Dosage Rationale Reference 9 63810 Protocols www. protocols. integrativeinc.com Zinc Saw Palmetto ( Serenoa repens ) Pumpkin ( Cucurbita pepo ) Pygeum ( Pygeum africanum ) Stinging Nettle  ( Urtica  dioica ) Lycopene Take twice daily. 15 mg 160 mg 100 mg 50 mg 50 mg 1 mg Additional Prostate Support Zinc is critical for proper cell growth, proliferation, metabolism and migration1 Saw palmetto inhibits prostate cell growth by up to 20-25% and cancer cell growth by up to 50% ( in vitro ); also reduces inflammation (COX-2)2 Pumpkin mildly inhibits 5-alpha reductase (enzyme which converts testosterone to ihydrotestosterone) ( in vivo ); reduces inflammation; and reduces prostate symptoms3 Pygeum improved micturition in 66% men after two months (clinical study)4 Meta analysis of 18 randomized controlled trials involving 1,562 men found that men who received pygeum extract were more than twice as likely to report improvements; nocturia was reduced by 19%, residual urine volume by 24% and peak urine flow increased by 23%5 Stinging nettle improved lower urinary tract symptoms for 81% of patients; peak flow rate increased 2.5 times that of placebo6 Research suggests lycopene may decrease growth of prostate cancer7 1. Costello LC, et al. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer. 2006 May 15;5(1):17 [Epub ahead of print] 2. Goldmann WH, et al. Saw palmetto berry extract inhibits cell growth and Cox-2 expression in prostatic cancer cells. Cell Biol Int . 2 001;25(11):1117-24. 3. Zhang X, et al. Effect of the extracts of pumpkin seeds on the urodynamics of rabbits: an experimental study. J Tongji Med Univ . 1994;14(4):235-8. 4. Barlet A, et al. Efficacy of Pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasia: evaluation of objective and subjective parameters. A placebo-controlled double- blind multicenter study. Wien Klin Wochenschr . 1990 Nov 23;102(22):667-73. 5. Ishani A, et al. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta- analysis. Am J Med . 2000 Dec 1;109(8):654-64. 6. Safarinejad MR. Urtica dioica for Treatment of Benign Prostatic HyperplasiaA Prospective, Randomized, Double-Blind, Placebo- Controlled, Crossover Study. J Herb Pharmacother . 2005;5(4):1-11. 7. Kucuk O, et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer  Epidemiol Biomarkers Prev . 2001;10:861-868. Prostate Cancer Cancer Treatment Adjuvant Ingredients Dosage Rationale Reference 10 63810 Protocols www. protocols. integrativeinc.com Calcium D-Glucarate Green Tea ( Camellia  sinensis ) Maitake ( Grifola frondosa ) Mushroom Lycopene Take twice daily with meals. 200 mg 50 mg 55 mg 2.5 mg Calcium D-glucarate Elevated beta-glucuronidase activity has been associated with an increased risk for various cancers, particularly hormone-dependent cancers such as breast, prostate, and colon cancers. Calcium D-glucarate inhibits activity of 尾- glucuronidase1,2 Green tea inhibits prostate cancer development, progression, and metastasis3,4 Maitake mushroom activates immune cells and possesses anti-tumor activities5 1. Walaszek Z, et al. Metabolism, uptake, and excretion of a Dglucaric acid salt and its potential use in cancer prevention. Cancer Detect Prev .1997;21:178-190. 2. Walaszek Z. Potential use of D-glucaric acid derivatives in cancer prevention. Cancer Lett 1990;54:1-8. 3. Gupta S, et al. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci U S A . 2001;98:10350-10355. 4. Chung LY, et al. Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sci . 2001;68:1207-1214. 5. Matsui K, et al. Effects of maitake (Grifola frondosa) D- Fraction on the carcinoma angiogenesis. Cancer Lett. 2001;172:193-198. Prostate Cancer Cancer Treatment Adjuvant Ingredients Dosage Rationale Reference 11 63810 Protocols www. protocols. integrativeinc.com ADDITIONAL SUPPORT FOR PROSTATE CANCER PREVENTION OR ESTROGEN DOMINANCE Stable, Bioavailable Diindolylmethane (DIM), co-solubilized with vitamin E and phosphatidylcholine,   for enhanced absorption and bioavailability 30 mg daily Estrogen Balance Shifts estrogen metabolism to C-2 pathway in liver, which increases ratio of 2-hydroxy and 2-methoxy estrogen metabolites over 16-hydroxyestrone estrogen metabolites1 Exhibits potent antiproliferative and antiandrogenic properties in androgen- dependent human prostate cancer cells2 Also reduces intracellular and secreted PSA levels2 1. Zeligs MA. Safer estrogen with phytonutrition. Towns Lett . 1999;189:83-88. 2. Le HT, et al. Plant-derived 3,3'- Diindolylmethane is a strong androgen antagonist in human prostate cancer cells. J Biol Chem . 2003 Jun 6;278(23):21136-45. Calcium D-Glucarate 0.5 - 1.5 g three times daily with meals Estrogen Detoxification Detoxifies estrogen and xenoestrogen by inhibiting beta-glucuronidase and preventing hydrolysis of their glucuronides1 1. Walaszek Z, et al. Metabolism, uptake, and excretion of a D- glucaric acid salt and its potential use in cancer prevention. Cancer Detect Prev . 1997;21(2):178-90. This Integrative Interventions protocol is sponsored by Integrative Therapeutics, Inc., Green Bay, WI, 54311 www.integrativeinc.com 1-800-931-1709 Prostate Cancer

   download Cancer Treatment Adjuvant Protocol - Prostate Cancer

Responses to Cancer Treatment Adjuvant Protocol - Prostate Cancer

It's no comment...

 

Your Name:
Your Email:
Your Talk: